Sean Grant - 14 Mar 2023 Form 4 Insider Report for Vera Therapeutics, Inc. (VERA)

Role
CHIEF FINANCIAL OFFICER
Signature
/s/ Joseph R. Young, Attorney-in-Fact
Issuer symbol
VERA
Transactions as of
14 Mar 2023
Net transactions value
$0
Form type
4
Filing time
05 Apr 2024, 21:27:39 UTC
Previous filing
17 Feb 2023
Next filing
23 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VERA Class A Common Stock Gift $0 -14,285 -29% $0.000000 35,648 14 Mar 2023 Direct F1
transaction VERA Class A Common Stock Gift $0 +14,285 +1440% $0.000000 15,277 14 Mar 2023 By Trust F2
transaction VERA Class A Common Stock Gift $0 -1,620 -8% $0.000000 18,657 24 Jul 2023 By Trust F3
transaction VERA Class A Common Stock Gift $0 -636 -3.4% $0.000000 18,021 20 Dec 2023 By Trust F1
transaction VERA Class A Common Stock Gift $0 +1,620 $0.000000 1,620 24 Jul 2023 As Custodian for UTMA account F4, F5
holding VERA Class A Common Stock 2,816 14 Mar 2023 By IRA
holding VERA Class A Common Stock 335 14 Mar 2023 By Roth IRA
holding VERA Class A Common Stock 857 14 Mar 2023 By Spouse's IRA
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the number of shares held directly at the time and after giving effect to the reported gift.
F2 Reflects the number of shares held by the trust at the time and after giving effect to the reported gift.
F3 Reflects the number of shares held by the trust at the time and after giving effect to the reported gift. The number also reflects a purchase reported on a Form 4 filed on June 23, 2023.
F4 The shares were acquired through a custodial account established for an immediate family member of the Reporting Person pursuant to the Uniform Transfers to Minors Act, for which the Reporting Person serves as a custodian.
F5 The Reporting Person disclaims beneficial ownership of these shares, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these shares for purposes of Section 16 or for any other purpose.